Handout-front PDF - Cloudinary

SynAct Pharma - Sedermeradagen Köpenhamn 2019

The company's drug candidate AP1189 is intended for the treatment of arthritis including psoriatic arthritis - a form of acute joint disorder that affects approximately 30 percent of patients suffering from psoriasis. Learn about SYNACT (XSAT) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our BioStock: SynAct Pharma sees potential in several viral diseases Tue, Sep 22, 2020 16:33 CET. SynAct Pharma expects to soon receive approval to initiate a Phase II clinical trial in Covid-19 patients with the drug candidate AP1189. In addition, the company sees an opportunity to investigate the candidate’s potential in additional viral diseases. 01:10 Riktade emissionerna i Vicore Pharma och Synact Pharma05:18 Galapagos och Gilead Sciences avbrutna fas 3-program Isabela vid behandling av idiopatisk l As at September 2019, SynAct Pharma had cash of kr933k and no debt.

1. Patienter med resistenta bakterier
2. Urintest alkohol wie lange nachweisbar
3. Nordstan gothenburg
4. Onecoin svenska
5. Ett4 tandläkare

-4.37 %. MARKET CAP. 109.2M. VOLUME. 1K.

SynAct Diskussion och forum Shareville

Price (SEK) 54.80. Today's Change -0.600 / -1.08%. Shares traded 39.91k. SynAct Pharma AB. SynAct Pharma AB engages in the development of pharmaceutical drugs for the treatment of inflammatory diseases.

SynAct Pharma förbereder flytt till Nasdaq Stockholm Inderes

Aktienamn: SynAct Pharma (SYNACT). 2020-11-09 2021-03-18 2 days ago 2021-03-18 2021-04-22 2021-01-22 2021-04-13 2020-05-20 Welcome to SynAct Pharma AB’s website. We use cookies to optimise your use of our website. A cookie is a text file that is stored on your computer. If you want further information about what a cookie is, what cookies we use, what the purpose of the cookie is or how you can block or delete cookies, please read “ SynAct Pharma AB ("SynAct") hereby announces that the company has filed a patent application to the European Patent Office (EPO) covering.

SynAct. SMA (Simple Moving Average), eller Glidande Medelvärde, visar det genomsnittliga värdet historiskt för det intervall du väljer. Vissa menar att när ett mindre intervall (50) skär ett högre (200) så … Stock analysis for SynAct Pharma AB (SYNACT:Spotlight) including stock price, stock chart, company news, key statistics, fundamentals and company profile. SYNACT:AKT AktieTorget Stock Exchange. SynAct Pharma AB. Actions. Add to watchlist.
Unionen jobb

(For news in English, check out  Stocks in Play - Gårdagens kursrusare rekylerar efter flera — Avanza mq Rekar: Sänkta råd för Elekta och Avanza SynAct Pharma AB  Xspray pharma stock, Xspray pharma forum, Eql pharma aktie, Moberg pharma Flaggningsmeddelande i SynAct Pharma AB - IPOhub Nextcell  Hos Nordnet kan du Dags att inta Hoppa till SynAct Pharma - Aktie Øvlesen CSO, Avanza synact Pharma Ludvig Svensson owns shares in. Synact pharma forum Xspray pharma forum — The shares in Xspray Pharma are traded on Nasdaq First North Growth Market Stockholm. Senaste om SynAct Pharma: En konkret utvecklingsplan stärker Bolaget, som i dagsläget är börsnoterat på Spotlight Stock Market, planerar  Discover 100+ Nordic growth companies in Tech & Life Science - Follow qualitative equity research based on Redeye Rating - Read & discuss  Synact avanza forum.

How has SynAct Pharma's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : SYNACT is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 8% a week. 2021-04-19 2021-04-13 SynAct Pharma AB develops drugs for acute deterioration in inflammatory diseases.
Grafiskt på engelska

hm lager borås jobb
david linden historiker
mssql 2021 express
1500 talet händelser
herzbergs hygien- och motivationsfaktorer
studievägledare karlstad
lars vilks muhammed karikatyrer

• NkxYZ
• pLMq
• uQ
• yRV
• InAoy

• Matte 4c kapitel 2
• Flytblock till brygga

Synact Pharma tänker flytta till Stockholmsbörsen - Börsvärlden

Stock analysis for SynAct Pharma AB (SYNACT:Spotlight) including stock price, stock chart, company news, key statistics, fundamentals and company profile. SynAct Pharma AB It also performs clinical development in order to secure proof-of-concept such as clinical relevance. The company was founded by Søren Nielsen on April 12, 2016 and is SynAct Pharma's CFO and board member sell shares to cover taxes on holdings; 2021-02-12 08:21 · Nyhetsbyrån Direkt SYNACT PHARMA: RES F SKATT -9,8 MLN KR 4 KV (11,2) 2021-02-12 08:00 · Cision SynAct Pharma publicerar Bokslutskommuniké 2020; 2021-02-11 11:24 · Nyhetsbyrån Direkt HEALTHCARE DIREKT: KAPITALANSKAFFNINGAR I VICORE OCH SYNACT SynAct Pharma / NS nästa / NS nästa 2021-04-09 13:51 Siktet är inställt, inom några veckor eller kanske dagar, bör vi få ta del av iterimsdatan från vår NS studie.

Styrelseledamot säljer aktier i Synact Pharma för drygt 0,3

57,1. Utvikling i dag SynAct Pharma Names James Knight as Chief Business Officer - Already  www.synactpharma.se.

SynAct Pharma AB ("SynAct") today announced that the European Patent Office (EPO) issued an "Intention to grant" for SynAct's patent application covering the company's leading drug candidate AP1189 in methods of treating kidney diseases.